Table 2.

Clinical characteristics and their prediction of overall survival in 362 HCC patients receiving surgical resection for the tumor

Characteristics	No of patients	No of events	5-y-survival (%)	Overall survival
				MST (95% CI)	Hazard ratio (95% CI)	P
Number	362	225	30	34.0 (27.4-40.6)
Age (year)
≤50	186	113	30	35.0 (23.2-46.7)	1.000
>50	176	112	29	33.0 (24.2-41.8)	1.098 (0.845-1.426)	0.483
Sex
Female	63	41	27	31.0 (24.2-37.8)	1.000
Male	299	184	30	37.0 (27.5-46.5)	0.885 (0.631-1.242)	0.481
Smoking
Never	224	144	26	31.0 (23.2-38.8)	1.000
Ever	138	81	37	39.0 (27.3-50.7)	0.858 (0.653-1.127)	0.270
Drinking
Never	142	86	28	35.0 (19.6-50.4)	1.000
Ever	220	139	31	33.0 (25.0-41.0)	1.071 (0.818-1.401)	0.619
Family history
Absent	263	158	31	37.0 (27.3-46.7)	1.000
Present	81	55	25	29.0 (17.4-40.6)	1.192 (0.877-1.620)	0.262
Unknow	18	12
HbsAg
Negative	59	40	35	22.0 (6.7-37.3)	1.000
Positive	303	185	28	37.0 (30.2-43.8)	0.913 (0.648-1.287)	0.603
AFP
Negative	142	95	26	33.0 (25.7-40.3)	1.000
Positive	214	127	32	35.0 (26.1-43.9)	0.892 (0.684-1.164)	0.400
Unknow	6	3
Tumor size (cm)
≤5	183	107	35	39.0 (28.1-49.9)	1.000
>5	179	118	24	30.0 (21.0-39.0)	1.343 (1.033-1.747)	0.028†
Differentiation
I+II	196	122	28	37.0 (27.5-46.5)	1.000
III+IV	155	96	32	34.0 (26.0-42.0)	0.926 (0.708-1.120)	0.572
Unknow	11	7
Tumor capsule
Absent	177	113	28	31.0 (22.7-39.3)	1.000
Present	181	110	31	37.0 (26.1-47.9)	0.913 (0.702-1.188)	0.499
Unknow	4	2
Venous invasion
Absent	257	150	33	39.0 (29.3-48.7)	1.000
Present	102	73	22	26.0 (20.1-31.9)	1.368 (1.033-1.811)	0.029†
Unknow	3	2
Cirrhosis
Absent	121	79	30	27.0 (13.6-40.4)	1.000
Present	239	145	30	36.0 (29.6-42.4)	0.949 (0.721-1.249)	0.708
Unknow	2	1
Tumor number
Solitary	279	172	30	34.0 (26.0-42.0)	1.000
Multiple	83	53	27	35.0 (24.5-45.5)	1.061 (0.780-1.445)	0.704
pTNM stage
I+II	309	188	31	37.0 (30.7-43.3)	1.000
III+IV	39	27	24	22.0 (13.0-31.0)	1.280 (0.855-1.916)	0.231
Unknow	14	10

Abbreviations: MST, median survival time; CI, confidence interval; AFP, α-fetoprotein.

^† P<0.05.